Journal: Journal of Experimental Pharmacology
Article Title: Artemisia annua Extract Ameliorates Atopic Dermatitis: Evidence from 3D Epidermal Model and Complementary in vitro Assays
doi: 10.2147/JEP.S550568
Figure Lengend Snippet: MβCD/IL-mix-induced AD-like phenotypes and expression of related genes in 3D epidermal models. ( a ) Histological sections of 3D models treated with different concentrations of MβCD/IL-4/IL-13/IL-25. 25: MβCD (7.5 mM), IL-4 (25 ng/mL), IL-13 (25 ng/mL), IL-25 (10 ng/mL); 50: MβCD (7.5 mM), IL-4 (50 ng/mL), IL-13 (50 ng/mL), IL-25 (20 ng/mL); 100: MβCD (7.5 mM), IL-4 (100 ng/mL), IL-13 (100 ng/mL), IL-25 (40 ng/mL). Scale bar 50 µm (n=3). ( b ) qPCR analysis (n=4) (* p < 0.05, ** p < 0.01, **** p < 0.0001, n.s., not significant). ( c ) Cytokine array TSLP and IL-1α analysis (n=3) (** p < 0.01, **** p < 0.0001).
Article Snippet: Protein concentration was determined by BCA assay, and cell lysates were resolved by SDS-PAGE on 4–12% gradient Bis-Tris gels (GenScript, M000138), transferred to PVDF membranes, and probed with antibodies against filaggrin (ThermoFisher, PA5-115235), IL-1α and TSLP (Cell Signaling Technology, 34819S and 97630S), p38 MAPK and p-p38 MAPK (Proteintech, 66234-1-Ig and 28796-1-AP), GAPDH (Cell Signaling Technology, 14C10), β-actin (Servicebio, GB15001-100), anti-rabbit IgG and anti-mouse IgG HRP-linked Antibody (Cell SignalingTechnology, 7074P2 and 7076P2).
Techniques: Expressing